TIANJIN PHARMACEUTICAL DA REN T

TIANJIN PHARMACEUTICAL DA REN T — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006	FY 2005Dec 31, 2005
+Revenue	7.3B	8.2B	8.2B	6.9B	6.6B	7.0B	6.4B	5.7B	6.2B	7.1B	7.1B	6.0B	5.1B	4.4B	3.5B	2.9B	2.4B	2.3B	2.2B	2.5B
Revenue Growth %	-11.1%	-0.3%	19.4%	4.6%	-5.6%	10.0%	11.8%	-8.9%	-11.8%	-0.1%	17.9%	17.2%	16.8%	26.5%	20.5%	21.8%	4.7%	4.3%	-14.0%	--
Total Revenue	7.3B	8.2B	8.2B	6.9B	6.6B	7.0B	6.4B	5.7B	6.2B	7.1B	7.1B	6.0B	5.1B	4.4B	3.5B	2.9B	2.4B	2.3B	2.2B	2.5B
Cost Of Revenue	3.8B	4.6B	5.0B	4.2B	4.0B	4.0B	3.7B	3.5B	4.2B	5.0B	4.9B	4.1B	3.3B	2.8B	2.1B	1.8B	1.5B	1.5B	1.4B	1.4B
+Gross Profit	3.5B	3.6B	3.3B	2.8B	2.6B	2.9B	2.6B	2.2B	2.0B	2.1B	2.2B	1.9B	1.8B	1.6B	1.3B	1.1B	891.0M	791.0M	772.0M	1.1B
Gross Margin %	48.2%	44.0%	39.9%	39.9%	39.0%	42.1%	41.5%	38.8%	32.5%	29.5%	30.4%	31.9%	34.9%	35.7%	38.5%	38.3%	37.7%	35.0%	35.7%	43.3%
Total Operating Cost	6.7B	7.5B	7.6B	6.3B	6.0B	6.5B	5.9B	5.4B	6.0B	6.7B	6.8B	5.7B	4.9B	4.2B	3.3B	2.8B	2.3B	2.5B	2.6B	2.5B
Selling Expenses	2.0B	2.1B	2.0B	1.6B	1.5B	1.8B	1.7B	1.4B	1.3B	1.3B	1.4B	1.2B	1.1B	901.0M	749.0M	623.0M	519.0M	522.0M	635.0M	655.0M
Admin Expenses	459.0M	382.0M	378.0M	373.0M	357.0M	365.0M	300.0M	288.0M	381.0M	349.0M	351.0M	330.0M	353.0M	335.0M	320.0M	291.0M	266.0M	329.0M	339.0M	374.0M
Rd Expenses	162.0M	185.0M	153.0M	161.0M	149.0M	133.0M	101.0M	79.4M	--	--	--	--	--	--	--	--	--	--	--	--
Finance Expenses	15.0M	-15.6M	-39.8M	-45.6M	-26.7M	-6.2M	5.5M	5.6M	20.1M	33.1M	51.0M	52.9M	54.4M	51.7M	41.2M	49.4M	74.2M	77.6M	51.5M	53.8M
+Operating Income	2.6B	1.1B	980.0M	867.0M	785.0M	759.0M	642.0M	526.0M	436.0M	499.0M	413.0M	405.0M	500.0M	272.0M	306.0M	209.0M	92.2M	-59.9M	-396.0M	81.7M
Operating Margin %	35.1%	13.3%	11.9%	12.6%	11.9%	10.9%	10.1%	9.2%	7.0%	7.0%	5.8%	6.7%	9.7%	6.2%	8.8%	7.3%	3.9%	-2.7%	-18.3%	3.2%
Non Operating Income	16.5M	3.1M	2.9M	9.3M	3.6M	923,500	2.2M	9.1M	33.2M	40.1M	20.3M	14.5M	21.0M	18.7M	53.6M	49.8M	75.4M	42.7M	8.8M	32.4M
Non Operating Expenses	4.4M	4.7M	2.8M	3.2M	20.7M	16.8M	3.1M	4.5M	2.9M	2.0M	2.7M	2.5M	3.4M	8.6M	6.6M	3.2M	4.7M	8.6M	3.3M	10.3M
Investment Income	1.9B	308.0M	274.0M	213.0M	160.0M	186.0M	165.0M	197.0M	180.0M	132.0M	83.6M	105.0M	277.0M	44.1M	106.0M	88.0M	73.9M	203.0M	62.5M	83.5M
Fair Value Change Income	--	--	--	--	--	-3.3M	3.3M	-660,000	660,000	1.5M	--	60,200	--	--	--	--	--	--	--	--
Asset Disposal Income	108,600	149,300	1.1M	12.3M	7.5M	29.9M	5.1M	5.7M	14.5M	--	--	--	--	--	--	--	--	--	--	--
Asset Impairment Loss	131.0M	71.9M	55.9M	10.3M	-4.1M	26.4M	16.1M	27.7M	55.8M	32.8M	6.3M	-12.8M	13.7M	15.9M	1.8M	-3.7M	-4.4M	108.0M	191.0M	--
Other Income	31.2M	21.8M	6.7M	10.9M	42.7M	11.9M	11.4M	8.1M	--	--	--	--	--	--	--	--	--	--	--	--
Income Before Tax	2.6B	1.1B	980.0M	873.0M	768.0M	743.0M	641.0M	531.0M	466.0M	537.0M	431.0M	417.0M	517.0M	282.0M	353.0M	256.0M	163.0M	-25.7M	-391.0M	105.0M
Income Tax	364.0M	127.0M	107.0M	85.9M	88.4M	108.0M	72.8M	57.7M	57.6M	79.3M	51.4M	56.5M	59.1M	15.0M	31.9M	-19.3M	-29.3M	20.6M	1.8M	11.8M
+Net Income	2.2B	969.0M	873.0M	787.0M	680.0M	635.0M	568.0M	473.0M	409.0M	458.0M	379.0M	361.0M	458.0M	267.0M	321.0M	275.0M	192.0M	-46.3M	-393.0M	93.2M
Net Margin %	30.3%	11.8%	10.6%	11.4%	10.3%	9.1%	8.9%	8.3%	6.6%	6.5%	5.3%	6.0%	8.9%	6.1%	9.2%	9.5%	8.1%	-2.0%	-18.2%	3.7%
Net Income Attributable	2.2B	987.0M	862.0M	769.0M	662.0M	626.0M	562.0M	476.0M	424.0M	451.0M	358.0M	352.0M	441.0M	248.0M	293.0M	258.0M	176.0M	-70.0M	-387.0M	80.8M
Minority Interest	-14.1M	-18.0M	11.5M	17.7M	18.0M	9.8M	6.1M	-2.8M	-14.8M	6.4M	21.6M	8.8M	17.0M	18.9M	27.6M	17.1M	16.1M	23.7M	-6.2M	12.4M
Eps Basic	2.90	1.28	1.12	1.00	0.86	0.81	0.73	0.62	0.55	0.60	0.48	0.48	0.60	0.33	0.40	0.35	0.48	-0.19	-1.05	0.22
Eps Diluted	2.89	1.28	1.11	1.00	0.86	0.81	0.73	0.62	0.55	0.60	0.48	0.48	0.60	0.33	0.40	0.35	0.48	-0.19	-1.05	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006	FY 2005Dec 31, 2005
Cash And Equivalents	2.9B	2.1B	2.9B	2.3B	2.0B	1.5B	1.5B	992.0M	1.2B	1.1B	631.0M	545.0M	420.0M	409.0M	372.0M	365.0M	362.0M	356.0M	332.0M	414.0M
Trading Financial Assets	--	--	--	--	--	43.5M	53.3M	--	660,000	1.5M	--	51.2M	--	--	--	--	--	--	--	--
Accounts Receivable	756.0M	2.2B	2.1B	1.5B	1.5B	1.4B	1.3B	1.2B	1.2B	1.3B	1.3B	1.0B	824.0M	635.0M	474.0M	440.0M	322.0M	271.0M	295.0M	394.0M
Notes Receivable	153.0M	52.4M	98.3M	334.0M	449.0M	--	387.0M	269.0M	266.0M	224.0M	303.0M	390.0M	288.0M	193.0M	168.0M	194.0M	118.0M	175.0M	83.5M	101.0M
Notes And Accounts Receivable	909.0M	2.2B	2.2B	1.9B	2.0B	1.4B	1.7B	1.5B	1.5B	1.5B	1.6B	1.4B	1.1B	828.0M	642.0M	634.0M	440.0M	446.0M	379.0M	495.0M
Prepayments	25.3M	75.7M	71.5M	48.5M	49.4M	120.0M	139.0M	161.0M	141.0M	119.0M	151.0M	87.2M	146.0M	136.0M	97.6M	70.4M	63.3M	50.1M	56.7M	65.6M
Inventory	1.3B	1.6B	1.4B	1.5B	1.5B	1.6B	1.3B	1.1B	929.0M	974.0M	860.0M	817.0M	772.0M	730.0M	598.0M	516.0M	441.0M	395.0M	491.0M	555.0M
Total Current Assets	6.6B	6.6B	7.2B	6.4B	5.6B	5.1B	4.8B	4.0B	4.0B	4.0B	3.4B	3.2B	2.5B	2.2B	1.8B	1.6B	1.4B	1.3B	1.3B	1.7B
Long Term Equity Investment	1.3B	882.0M	760.0M	730.0M	688.0M	658.0M	631.0M	562.0M	561.0M	531.0M	542.0M	525.0M	674.0M	507.0M	551.0M	534.0M	532.0M	515.0M	503.0M	518.0M
Fixed Assets	--	1.0B	1.1B	1.2B	1.2B	1.2B	840.0M	796.0M	828.0M	794.0M	807.0M	842.0M	876.0M	1.1B	1.1B	1.1B	1.1B	1.2B	1.3B	1.4B
Fixed Assets Total	950.0M	1.0B	1.1B	1.2B	1.2B	1.2B	840.0M	796.0M	828.0M	794.0M	807.0M	842.0M	876.0M	1.1B	1.1B	1.1B	1.2B	1.2B	1.3B	1.4B
Construction In Progress	--	386.0M	334.0M	332.0M	285.0M	203.0M	360.0M	280.0M	167.0M	127.0M	62.9M	44.0M	33.1M	32.8M	64.7M	34.6M	38.1M	39.1M	17.8M	188.0M
Construction In Progress Total	436.0M	386.0M	334.0M	332.0M	285.0M	203.0M	360.0M	280.0M	167.0M	127.0M	62.9M	44.0M	33.1M	32.8M	64.7M	34.6M	38.1M	39.1M	17.8M	188.0M
Intangible Assets	295.0M	318.0M	281.0M	198.0M	203.0M	174.0M	174.0M	178.0M	179.0M	186.0M	191.0M	197.0M	178.0M	198.0M	203.0M	199.0M	190.0M	172.0M	214.0M	243.0M
Long Term Deferred Expenses	23.7M	5.2M	6.5M	7.6M	7.3M	6.8M	8.7M	5.7M	10.8M	13.1M	15.1M	17.9M	10.0M	14.5M	12.5M	6.7M	4.5M	--	3.2M	--
Total Non Current Assets	4.2B	3.7B	2.9B	2.6B	2.7B	2.7B	2.3B	2.7B	2.5B	2.1B	2.1B	2.1B	1.9B	2.0B	2.1B	2.0B	2.1B	2.1B	2.2B	2.4B
Total Assets	10.8B	10.2B	10.2B	9.1B	8.3B	7.8B	7.1B	6.6B	6.4B	6.1B	5.4B	5.3B	4.5B	4.1B	3.8B	3.7B	3.4B	3.5B	3.6B	4.1B
Short Term Borrowings	21.7M	81.8M	102.0M	--	--	--	252.0M	262.0M	304.0M	419.0M	786.0M	1.1B	874.0M	692.0M	648.0M	778.0M	812.0M	550.0M	695.0M	905.0M
Accounts Payable	285.0M	615.0M	724.0M	599.0M	666.0M	661.0M	588.0M	538.0M	546.0M	645.0M	659.0M	554.0M	520.0M	474.0M	423.0M	449.0M	296.0M	286.0M	301.0M	226.0M
Advance Receipts	418,200	--	--	--	--	--	--	55.1M	66.7M	64.6M	51.4M	78.8M	76.3M	58.6M	52.6M	26.3M	40.3M	30.6M	21.5M	24.5M
Contract Liabilities	123.0M	146.0M	219.0M	216.0M	247.0M	364.0M	235.0M	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	2.8B	3.2B	3.3B	2.4B	2.2B	2.2B	1.9B	1.9B	2.0B	1.8B	2.4B	2.6B	2.1B	1.9B	1.5B	1.7B	1.9B	1.9B	1.6B	1.7B
Long Term Borrowings	--	241.0M	151.0M	--	30.0M	30.0M	--	--	--	--	--	--	--	1.2M	144.0M	100.0M	--	120.0M	540.0M	379.0M
Total Non Current Liabilities	101.0M	352.0M	272.0M	119.0M	170.0M	163.0M	137.0M	135.0M	130.0M	123.0M	129.0M	135.0M	56.8M	69.0M	217.0M	170.0M	35.7M	216.0M	613.0M	390.0M
Total Liabilities	2.9B	3.6B	3.6B	2.6B	2.3B	2.3B	2.1B	2.0B	2.1B	2.0B	2.5B	2.7B	2.2B	1.9B	1.8B	1.9B	2.0B	2.1B	2.2B	2.1B
Paid In Capital	770.0M	770.0M	773.0M	773.0M	774.0M	773.0M	769.0M	769.0M	769.0M	769.0M	739.0M	739.0M	739.0M	739.0M	739.0M	370.0M	370.0M	370.0M	370.0M	370.0M
Capital Reserve	975.0M	975.0M	1.0B	1.4B	1.4B	1.3B	1.3B	1.3B	1.4B	1.3B	523.0M	523.0M	556.0M	595.0M	611.0M	994.0M	980.0M	1.0B	1.0B	930.0M
Surplus Reserve	437.0M	437.0M	437.0M	437.0M	437.0M	436.0M	434.0M	434.0M	384.0M	357.0M	311.0M	276.0M	242.0M	188.0M	165.0M	142.0M	142.0M	142.0M	142.0M	191.0M
Retained Earnings	5.6B	4.4B	4.3B	3.8B	3.2B	2.8B	2.3B	1.9B	1.6B	1.4B	1.1B	844.0M	600.0M	361.0M	284.0M	13.2M	-245.0M	-443.0M	-370.0M	140.0M
Minority Equity	6.3M	44.5M	30.5M	149.0M	141.0M	135.0M	127.0M	149.0M	163.0M	183.0M	183.0M	158.0M	142.0M	322.0M	287.0M	268.0M	237.0M	236.0M	231.0M	317.0M
Equity Attributable	7.8B	6.6B	6.5B	6.4B	5.8B	5.4B	4.9B	4.5B	4.2B	3.9B	2.8B	2.4B	2.1B	1.9B	1.8B	1.5B	1.2B	1.1B	1.2B	1.6B
Total Equity	7.8B	6.6B	6.6B	6.5B	6.0B	5.5B	5.1B	4.6B	4.3B	4.1B	2.9B	2.6B	2.3B	2.2B	2.1B	1.8B	1.5B	1.3B	1.4B	1.9B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006	FY 2005Dec 31, 2005
Cash From Sales	8.1B	9.5B	8.6B	7.5B	6.1B	6.5B	6.0B	5.4B	5.5B	5.9B	5.5B	4.8B	4.2B	3.7B	3.4B	3.1B	2.7B	2.5B	2.5B	3.2B
Tax Refunds Received	7.1M	20.5M	32.6M	14.8M	7.8M	3.4M	2.5M	3.6M	5.5M	5.1M	2.8M	4.0M	4.1M	4.0M	2.9M	2.0M	3.4M	6.2M	5.6M	--
Total Operating Cash Inflow	8.3B	9.7B	8.8B	7.6B	6.2B	6.5B	6.1B	5.4B	5.5B	5.9B	5.6B	4.9B	4.2B	3.8B	3.4B	3.2B	2.8B	2.6B	2.5B	3.2B
Cash Paid For Goods	3.9B	5.5B	5.1B	3.8B	2.8B	3.1B	3.0B	3.0B	2.9B	3.3B	3.2B	2.7B	2.4B	2.0B	1.9B	1.8B	1.6B	1.5B	1.4B	1.7B
Cash Paid To Employees	993.0M	938.0M	924.0M	913.0M	817.0M	836.0M	739.0M	663.0M	644.0M	579.0M	551.0M	523.0M	470.0M	445.0M	398.0M	350.0M	315.0M	320.0M	323.0M	351.0M
Taxes Paid	759.0M	786.0M	559.0M	511.0M	531.0M	602.0M	557.0M	518.0M	493.0M	511.0M	515.0M	499.0M	428.0M	378.0M	331.0M	257.0M	264.0M	204.0M	200.0M	178.0M
Total Operating Cash Outflow	7.3B	9.0B	8.1B	6.8B	5.6B	6.0B	5.7B	5.4B	5.1B	5.6B	5.3B	4.7B	4.2B	3.6B	3.3B	3.1B	2.7B	2.6B	2.6B	2.9B
Operating Cash Flow	925.0M	688.0M	677.0M	852.0M	671.0M	495.0M	350.0M	-4.0M	418.0M	361.0M	287.0M	213.0M	20.8M	174.0M	139.0M	83.4M	114.0M	20.1M	-28.1M	262.0M
Total Investing Cash Inflow	1.8B	228.0M	673.0M	195.0M	34.7B	71.7B	39.2B	37.6B	36.1B	23.9B	21.3B	3.1B	274.0M	80.4M	106.0M	136.0M	155.0M	317.0M	191.0M	88.5M
Total Investing Cash Outflow	1.5B	797.0M	686.0M	507.0M	34.7B	71.8B	38.9B	37.4B	36.1B	24.4B	21.2B	3.2B	252.0M	46.7M	93.9M	114.0M	57.7M	63.3M	70.2M	150.0M
Investing Cash Flow	342.0M	-569.0M	-12.3M	-312.0M	73.8M	-101.0M	382.0M	197.0M	86.6M	-428.0M	102.0M	-166.0M	22.4M	33.7M	11.8M	22.0M	97.6M	254.0M	121.0M	-61.3M
Cash From Borrowings	1.2B	871.0M	204.0M	--	--	130.0M	372.0M	382.0M	746.0M	807.0M	1.0B	1.6B	1.2B	882.0M	848.0M	960.0M	945.0M	875.0M	1.2B	2.1B
Dividends And Interest Paid	1.0B	877.0M	402.0M	242.0M	244.0M	176.0M	170.0M	133.0M	213.0M	151.0M	123.0M	158.0M	138.0M	204.0M	45.8M	56.9M	84.4M	89.0M	136.0M	136.0M
Debt Repayments	520.0M	801.0M	24.2M	--	--	352.0M	382.0M	425.0M	765.0M	1.2B	1.3B	1.4B	1.1B	877.0M	928.0M	1.0B	1.1B	1.0B	1.2B	2.1B
Total Financing Cash Inflow	1.2B	874.0M	206.0M	--	8.4M	158.0M	12.8B	10.9B	14.6B	38.4B	39.8B	4.6B	1.2B	884.0M	853.0M	980.0M	956.0M	875.0M	1.2B	2.2B
Total Financing Cash Outflow	1.5B	1.7B	442.0M	245.0M	246.0M	529.0M	13.0B	11.0B	14.9B	38.2B	40.3B	4.3B	1.3B	1.1B	974.0M	1.1B	1.2B	1.1B	1.4B	2.2B
Financing Cash Flow	-320.0M	-834.0M	-237.0M	-245.0M	-237.0M	-370.0M	-252.0M	-161.0M	-339.0M	274.0M	-491.0M	266.0M	-75.3M	-198.0M	-121.0M	-86.3M	-247.0M	-234.0M	-188.0M	-67.3M
Net Change In Cash	947.0M	-714.0M	428.0M	296.0M	508.0M	24.3M	480.0M	32.1M	165.0M	206.0M	-102.0M	315.0M	-32.0M	9.8M	29.9M	19.2M	-35.3M	40.9M	-94.9M	133.0M
Ending Cash Balance	2.9B	2.0B	2.7B	2.3B	2.0B	1.5B	1.5B	975.0M	943.0M	763.0M	557.0M	659.0M	345.0M	377.0M	367.0M	337.0M	318.0M	353.0M	312.0M	--
Capex	118.0M	141.0M	108.0M	157.0M	189.0M	206.0M	176.0M	114.0M	118.0M	92.6M	70.2M	72.4M	41.2M	43.0M	68.8M	86.7M	38.4M	53.7M	63.7M	150.0M